Aldo Amatucci

697 total citations
12 papers, 550 citations indexed

About

Aldo Amatucci is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Aldo Amatucci has authored 12 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Aldo Amatucci's work include NF-κB Signaling Pathways (4 papers), Immune Response and Inflammation (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Aldo Amatucci is often cited by papers focused on NF-κB Signaling Pathways (4 papers), Immune Response and Inflammation (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Aldo Amatucci collaborates with scholars based in United States, United Kingdom and Italy. Aldo Amatucci's co-authors include Jennifer S. Michaelson, Xiufeng Wu, Raghu Kalluri, Caroline Miller, Flora Huang, Brian Miller, Scott Glaser, Dominic Cosgrove, William B. Snyder and Victor Kotelianski and has published in prestigious journals such as Journal of the American Society of Nephrology, American Journal Of Pathology and Journal of Leukocyte Biology.

In The Last Decade

Aldo Amatucci

12 papers receiving 537 citations

Peers

Aldo Amatucci
Consuelo Anzilotti United Kingdom
J Sorvillo United States
Wim P.M. Tamboer Netherlands
Maria C. Melander Denmark
E. J. Davies United Kingdom
Begoña Santiago Spain
F I Preffer United States
Urs Wirthmueller Switzerland
Monica Schaller Switzerland
Brandt Levitt United States
Consuelo Anzilotti United Kingdom
Aldo Amatucci
Citations per year, relative to Aldo Amatucci Aldo Amatucci (= 1×) peers Consuelo Anzilotti

Countries citing papers authored by Aldo Amatucci

Since Specialization
Citations

This map shows the geographic impact of Aldo Amatucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Amatucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Amatucci more than expected).

Fields of papers citing papers by Aldo Amatucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldo Amatucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Amatucci. The network helps show where Aldo Amatucci may publish in the future.

Co-authorship network of co-authors of Aldo Amatucci

This figure shows the co-authorship network connecting the top 25 collaborators of Aldo Amatucci. A scholar is included among the top collaborators of Aldo Amatucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aldo Amatucci. Aldo Amatucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Vollmann, Elisabeth H., Lizhi Cao, Aldo Amatucci, et al.. (2017). Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing. Molecular Therapy — Nucleic Acids. 7. 314–323. 29 indexed citations
2.
Wilhelm, A, Emma L. Shepherd, Aldo Amatucci, et al.. (2016). Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation. The Journal of Pathology. 239(1). 109–121. 48 indexed citations
3.
Gomez, Ivan G., Allie M. Roach, Naoki Nakagawa, et al.. (2016). TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease. Journal of the American Society of Nephrology. 27(12). 3639–3652. 36 indexed citations
4.
Dohi, Taeko, Rei Kawashima, Yuki I. Kawamura, et al.. (2014). Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis. Cytokine. 69(1). 14–21. 13 indexed citations
5.
Chapman, Mark S., Lan Wu, Aldo Amatucci, Steffan N. Ho, & Jennifer S. Michaelson. (2012). TWEAK signals through JAK–STAT to induce tumor cell apoptosis. Cytokine. 61(1). 210–217. 17 indexed citations
6.
Michaelson, Jennifer S., Aldo Amatucci, Rebecca K. Kelly, et al.. (2011). Development of an Fn14 agonistic antibody as an anti-tumor agent. mAbs. 3(4). 362–375. 38 indexed citations
7.
Miller, Brian, Stephen J. Demarest, Alexey A. Lugovskoy, et al.. (2010). Stability engineering of scFvs for the development of bispecific and multivalent antibodies. Protein Engineering Design and Selection. 23(7). 549–557. 102 indexed citations
8.
Michaelson, Jennifer S., Stephen J. Demarest, Brian Miller, et al.. (2009). Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR. mAbs. 1(2). 128–141. 90 indexed citations
9.
Amatucci, Aldo, Tatiana I. Novobrantseva, Kevin Gilbride, et al.. (2007). Recombinant ST2 boosts hepatic Th2 response in vivo. Journal of Leukocyte Biology. 82(1). 124–132. 21 indexed citations
10.
Cosgrove, Dominic, Daniel T. Meehan, Caroline Miller, et al.. (2000). Integrin α1β1 and Transforming Growth Factor-β1 Play Distinct Roles in Alport Glomerular Pathogenesis and Serve as Dual Targets for Metabolic Therapy. American Journal Of Pathology. 157(5). 1649–1659. 152 indexed citations
11.
Raponi, Giammarco, et al.. (1997). Characterisation and protective capacity of monoclonal antibodies elicited in mice against protein epitopes of antibiotic-exposed Escherichia coli. Journal of Medical Microbiology. 46(2). 122–128. 2 indexed citations
12.
Amatucci, Aldo, Giammarco Raponi, Armando Bartolazzi, et al.. (1994). Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections. Journal of Medical Microbiology. 41(3). 179–183. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Consuelo Anzilotti Breakdown of academic impact, for papers by J Sorvillo Breakdown of academic impact, for papers by Wim P.M. Tamboer Breakdown of academic impact, for papers by Maria C. Melander Breakdown of academic impact, for papers by E. J. Davies Breakdown of academic impact, for papers by Begoña Santiago Breakdown of academic impact, for papers by F I Preffer Breakdown of academic impact, for papers by Urs Wirthmueller Breakdown of academic impact, for papers by Monica Schaller Breakdown of academic impact, for papers by Brandt Levitt
Rankless by CCL
2026